Use of Insulin Sensitizers in NASH

Mouen Khashab, Naga Chalasani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

Original languageEnglish
Pages (from-to)1067-1087
Number of pages21
JournalEndocrinology and Metabolism Clinics of North America
Volume36
Issue number4
DOIs
StatePublished - Dec 2007

Fingerprint

Natural History
Liver
Insulin
Safety
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Use of Insulin Sensitizers in NASH. / Khashab, Mouen; Chalasani, Naga.

In: Endocrinology and Metabolism Clinics of North America, Vol. 36, No. 4, 12.2007, p. 1067-1087.

Research output: Contribution to journalArticle

@article{50acc0df47ba43d2b21ab2f6d5afe291,
title = "Use of Insulin Sensitizers in NASH",
abstract = "This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.",
author = "Mouen Khashab and Naga Chalasani",
year = "2007",
month = "12",
doi = "10.1016/j.ecl.2007.07.006",
language = "English",
volume = "36",
pages = "1067--1087",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Use of Insulin Sensitizers in NASH

AU - Khashab, Mouen

AU - Chalasani, Naga

PY - 2007/12

Y1 - 2007/12

N2 - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

AB - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

UR - http://www.scopus.com/inward/record.url?scp=35648951688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648951688&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2007.07.006

DO - 10.1016/j.ecl.2007.07.006

M3 - Article

VL - 36

SP - 1067

EP - 1087

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 4

ER -